Literature DB >> 29464732

Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?

Sibylle Neuhoff1, Geoffrey T Tucker2.   

Abstract

Entities:  

Keywords:  4β-hydroxycholesterol; CYP3A4; biomarker

Mesh：

Substances：

Year:  2018        PMID： 29464732      PMCID： PMC6005580          DOI： 10.1111/bcp.13538

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  14 in total

1.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters.

Authors:  Stephen Ph Alexander; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

2.  Pregnane X receptor-agonists down-regulate hepatic ATP-binding cassette transporter A1 and scavenger receptor class B type I.

Authors:  Marita Sporstøl; German Tapia; Lene Malerød; Seyed Ali Mousavi; Trond Berg
Journal:  Biochem Biophys Res Commun       Date:  2005-06-17       Impact factor: 3.575

3.  Pretransplant 4β-hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation.

Authors:  Thomas Vanhove; Mahmoud Hasan; Pieter Annaert; Stefan Oswald; Dirk R J Kuypers
Journal:  Br J Clin Pharmacol       Date:  2017-07-14       Impact factor: 4.335

4.  Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-08-26       Impact factor: 4.052

5.  Plasma 4beta-hydroxycholesterol: an endogenous CYP3A metric?

Authors:  D Tomalik-Scharte; D Lütjohann; O Doroshyenko; D Frank; A Jetter; U Fuhr
Journal:  Clin Pharmacol Ther       Date:  2009-05-20       Impact factor: 6.875

6.  Metabolism of 4 beta -hydroxycholesterol in humans.

Authors:  Karl Bodin; Ulla Andersson; Eva Rystedt; Ewa Ellis; Maria Norlin; Irina Pikuleva; Gösta Eggertsen; Ingemar Björkhem; Ulf Diczfalusy
Journal:  J Biol Chem       Date:  2002-06-20       Impact factor: 5.157

7.  4beta-hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin.

Authors:  Ulf Diczfalusy; Kajsa P Kanebratt; Eva Bredberg; Tommy B Andersson; Ylva Böttiger; Leif Bertilsson
Journal:  Br J Clin Pharmacol       Date:  2008-11-06       Impact factor: 4.335

8.  PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine.

Authors:  Tiangang Li; Wenling Chen; John Y L Chiang
Journal:  J Lipid Res       Date:  2006-11-06       Impact factor: 5.922

9.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

10.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Nuclear hormone receptors.

Authors:  Stephen Ph Alexander; John A Cidlowski; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739
View more
  8 in total

1.  Effect of Grapefruit Juice Intake on Serum Level of the Endogenous CYP3A4 Metabolite 4β-Hydroxycholesterol-an Interaction Study in Healthy Volunteers.

Authors:  Caroline Gjestad; Kristine Hole; Tore Haslemo; Ulf Diczfalusy; Espen Molden
Journal:  AAPS J       Date:  2019-04-24       Impact factor: 4.009

2.  Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?

Authors:  Sibylle Neuhoff; Geoffrey T Tucker
Journal:  Br J Clin Pharmacol       Date:  2018-02-21       Impact factor: 4.335

3.  Kuypers and Vanhove reply to 'Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and Tucker.

Authors:  Dirk R J Kuypers; Thomas Vanhove
Journal:  Br J Clin Pharmacol       Date:  2018-04-24       Impact factor: 4.335

4.  Gjestad et al. reply to 'Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and Tucker.

Authors:  Caroline Gjestad; Tore Haslemo; Ole A Andreassen; Espen Molden
Journal:  Br J Clin Pharmacol       Date:  2018-05-10       Impact factor: 4.335

5.  Guidance for Rifampin and Midazolam Dosing Protocols To Study Intestinal and Hepatic Cytochrome P450 (CYP) 3A4 Induction and De-induction.

Authors:  Asha J Kapetas; Michael J Sorich; A David Rodrigues; Andrew Rowland
Journal:  AAPS J       Date:  2019-06-19       Impact factor: 4.009

6.  Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range.

Authors:  Kine Eide Kvitne; Kristine Hole; Veronica Krogstad; Birgit Malene Wollmann; Christine Wegler; Line K Johnson; Jens K Hertel; Per Artursson; Cecilia Karlsson; Shalini Andersson; Tommy B Andersson; Rune Sandbu; Jøran Hjelmesæth; Eva Skovlund; Hege Christensen; Rasmus Jansson-Löfmark; Anders Åsberg; Espen Molden; Ida Robertsen
Journal:  Eur J Clin Pharmacol       Date:  2022-06-01       Impact factor: 3.064

Review 7.  A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates.

Authors:  Anne Smits; Pieter Annaert; Steven Van Cruchten; Karel Allegaert
Journal:  Front Pharmacol       Date:  2020-05-13       Impact factor: 5.810

Review 8.  Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time.

Authors:  Norint P Tung; Joseph D Ma
Journal:  Eur J Clin Pharmacol       Date:  2022-09-13       Impact factor: 3.064
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.